RAVmed unit Lucid Diagnostics files IPO plan

Lucid is focused on patients with gastroesophageal reflux disease, also known as chronic heartburn or acid reflux, who are at risk of developing esophageal cancer.

Source: bizjournals.com Health Care:Biotechnology headlines - September 23, 2021 Category: Biotechnology Authors: I-Chun Chen Source Type: news